The world`s first malaria vaccine, made by GlaxoSmithKline, could be approved by international regulators for use in Africa from October after final trial data showed it offered partial protection for up to four years.
An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine.
A new hepatitis C vaccine from GlaxoSmithKline based on the same technology as an experimental Ebola shot being fast-tracked through human trials has shown promise in early clinical tests, prompting strong and broad immune responses.
A key safety trial of an experimental Ebola vaccine manufactured by GlaxoSmithKline has injected 10 healthy volunteers since Sept. 2, and so far "no red flags" indicating serious adverse reactions have been found.
Clinical trials of a preventative vaccine for the Ebola virus made by British pharma company GlaxoSmithKline may begin next month and made available by 2015, the World Health Organisation said on Saturday.
A foreign couple, stated to be private detectives hired by British drug maker GlaxoSmithKline (GSK), was indicted by Chinese prosecutors in Shanghai for illegally obtaining private information of Chinese citizens.
Scientists have found that the sleep disorder narcolepsy can sometimes be triggered by a scientific phenomenon known as "molecular mimicry", offering a possible explanation for its link to a GlaxoSmithKline H1N1 pandemic flu vaccine.
An experimental GlaxoSmithKline drug, designed to fight heart disease in a new way, failed to meet its main goal in a major late-stage clinical study, dealing a blow to one of the company`s biggest new treatment hopes.
Drug firm Jubilant Life Sciences Ltd Friday said it has received approval from the US Food and Drugs Administration (USFDA) to market generic versions of GlaxoSmithKline`s anti-depressant Wellbutrin SR and smoking cessation aid, Zyban.
British drugmaker GlaxoSmithKline will seek marketing approval for the world`s first malaria vaccine next year after trial data showed the shot significantly cut cases of the disease in African children.